Our Parent Company

Stemedica Cell Technologies Inc. is an FDB-licensed manufacturer of cGMP, clinical-grade stem cells currently used in several worldwide clinical trials, including the U.S.  Stemedica conducts multiple clinical trials with stem cells in several countries, and for many indications, including heart diseases, Alzheimer’s disease, skin aging, and ischemic stroke.  Please visit the Stemedica website for more details – www.stemedica.com.